The Journal of Pediatrics
Volume 156, Issue 5 , Pages 823-827 , May 2010

Long-Term Treatment of Cystinosis in Children with Twice-Daily Cysteamine

Received 9 July 2009 ,Revised 21 September 2009 ,Accepted 19 November 2009.

References 

  1. Gahl WA, Thoene JG, Schneider JA. Cystinosis. N Engl J Med. 2002;347:111–121
  2. Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, et al. Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med. 1987;316:971–977
  3. Markello TC, Bernardini IM, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med. 1993;328:1157–1162
  4. Wenner WJ, Murphy JL. The effects of cysteamine on the upper gastrointestinal tract of children with cystinosis. Pediatr Nephrol. 1997;11:600–603
  5. Elenberg E, Norling LL, Kleinman RE, Ingelfinger JR. Feeding problems in cystinosis. Pediatr Nephrol. 1998;12:365–370
  6. Dohil R, Newbury RO, Sellers ZM, Deutsch R, Schneider JA. The evaluation and treatment of gastrointestinal disease in children with cystinosis receiving cysteamine. J Pediatr. 2003;143:224–230
  7. Schneider JA. Treatment of cystinosis: simple in principle, difficult in practice. J Pediatr. 2004;145:436–438
  8. Dohil R, Fidler M, Barshop BA, Gangoiti J, Deutsch R, Martin M, et al. Understanding intestinal cysteamine bitartrate absorption. J Pediatr. 2006;148:764–769
  9. Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA. Cystinosis: intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976;58:180–189
  10. Dohil R. Twice daily cysteamine therapy for cystinosis. J Pediatr. 2010;156:71–75
  11. Smith M, Furlong CE, Greene AA, Schneider JA. Cystine-binding protein assay for cystine. Methods Enzymol. 1987;143:144–148
  12. Dohil R, Fidler M, Barshop B, Newbury R, Sellers Z, Deutsch R, et al. Esomeprazole therapy for gastric acid hypersecretion in children with cystinosis. Pediatr Nephrol. 2005;20:1786–1793
  13. Guan XHG, Dwivedi C, Matthees DP. A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homocysteine and their disulfides in biological samples. J Pharmaceut Biomed Anal. 2003;31:251–261
  14. McLean RA, Stroup WW. A unified approach to mixed linear models. Am Stat. 1991;45:54–63
  15. Littell RC, Ammerman CB. Statistical analysis of repeated measures data using SAS procedures. J Anim Sci. 1998;76:1216–1231
  16. Lalonde RL, Kowalski KG, Hutmacher MM, Ewy W, Nichols DJ, Milligan PA, et al. Model-based drug development. Clin Pharmacol Ther. 2007;82:21–32
  17. Schwartz GJ, Edelman CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasm creatinine. Pediatrics. 1976;58:259–263
  18. Kleta R. A deeper look into cysteamine absorption for the treatment of cystinosis. J Pediatr. 2006;148:718–719

 Supported by the Cystinosis Research Foundation (Irvine, CA) and the National Institutes of Health (grant MO1RR00827). The authors declare no conflicts of interest.

PII: S0022-3476(09)01194-9

doi: 10.1016/j.jpeds.2009.11.059

The Journal of Pediatrics
Volume 156, Issue 5 , Pages 823-827 , May 2010

Article Tools

* Image Usage & Resolution